Presentation is loading. Please wait.

Presentation is loading. Please wait.

TNF-α Antagonist and Vascular Inflammation in Patients with Psoriasis Vulgaris: A Randomized Placebo-Controlled Study  Robert Bissonnette, François Harel,

Similar presentations


Presentation on theme: "TNF-α Antagonist and Vascular Inflammation in Patients with Psoriasis Vulgaris: A Randomized Placebo-Controlled Study  Robert Bissonnette, François Harel,"— Presentation transcript:

1 TNF-α Antagonist and Vascular Inflammation in Patients with Psoriasis Vulgaris: A Randomized Placebo-Controlled Study  Robert Bissonnette, François Harel, James G. Krueger, Marie-Claude Guertin, Malorie Chabot-Blanchet, Juana Gonzalez, Catherine Maari, Isabelle Delorme, Charles W. Lynde, Jean-Claude Tardif  Journal of Investigative Dermatology  Volume 137, Issue 8, Pages (August 2017) DOI: /j.jid Copyright © 2017 The Authors Terms and Conditions

2 Figure 1 CONSORT diagram. SAE, serious adverse event.
Journal of Investigative Dermatology  , DOI: ( /j.jid ) Copyright © 2017 The Authors Terms and Conditions

3 Figure 2 Association between PASI at baseline and baseline cytokines levels. There was a significant positive correlation between PASI and serum levels of TNF-α, IL-17A, and S100A9 and a trend with IL-22. There was no significant correlation between PASI and serum levels of IL-6. PASI, Psoriasis Area and Severity Index. Journal of Investigative Dermatology  , DOI: ( /j.jid ) Copyright © 2017 The Authors Terms and Conditions


Download ppt "TNF-α Antagonist and Vascular Inflammation in Patients with Psoriasis Vulgaris: A Randomized Placebo-Controlled Study  Robert Bissonnette, François Harel,"

Similar presentations


Ads by Google